Detected ·
OMass Therapeutics
$310MSeries C
OMass Therapeutics raised an oversubscribed $310M Series C to fund its drug discovery programmes through clinical proof of concept for congenital adrenal hyperplasia and immunological indications.
- Website
- —
- linkedin.com/company/12654474
- Amount
- $310 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-10-22 16:07:46 UTC
- Signal ID
- 38bad071-5f05-4920-817f-2aec6ebd73bd
As the API returns it
{
"id": "38bad071-5f05-4920-817f-2aec6ebd73bd",
"created_at": "2026-10-22T16:07:46.445054Z",
"company_name": "OMass Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/12654474",
"event_type": "funding",
"funding_amount": 310000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*OMass Therapeutics raised an oversubscribed $310M Series C to fund its drug discovery programmes through clinical proof of concept for congenital adrenal hyperplasia and immunological indications.*"
}